Solana Co. Files 8-K with Financials

TL;DR

Solana Co. (fka Helius Medical) filed an 8-K on 10/29/25 with financials.

AI Summary

Solana Co. (formerly Helius Medical Technologies, Inc.) filed an 8-K on October 29, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, incorporated in Delaware with its principal executive offices in Newtown, PA, operates in the electromedical and electrotherapeutic apparatus sector.

Why It Matters

This filing provides updated information and financial disclosures for Solana Co., which may impact investor understanding of the company's current status and performance.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically contains standard corporate disclosures and does not inherently signal significant new risks.

Key Numbers

• 001-38445 — Commission File Number (Identifies the company's SEC filing history)
• 36-4787690 — IRS Employer Identification No. (Company's tax identification number)

Key Players & Entities

• Solana Co. (company) — Registrant
• Helius Medical Technologies, Inc. (company) — Former company name
• October 29, 2025 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• Newtown, PA (location) — Principal executive address

FAQ

Key Financial Figures

• $0.001 — hich registered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar

Filing Documents

• hsdt-20251029x8k.htm (8-K) — 42KB
• hsdt-20251029xex99d1.htm (EX-99.1) — 18KB
• hsdt-20251029x8k001.jpg (GRAPHIC) — 6KB
• 0001104659-25-103714.txt ( ) — 192KB
• hsdt-20251029.xsd (EX-101.SCH) — 3KB
• hsdt-20251029_lab.xml (EX-101.LAB) — 16KB
• hsdt-20251029_pre.xml (EX-101.PRE) — 10KB
• hsdt-20251029x8k_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On October 29, 2025, Solana Company (formerly known as Helius Medical Technologies, Inc.) (the "Company") issued a press release. After issuance of the press release, a correction was released that same day noting that in the first sentence of the third paragraph the amount of "SOL" held by the Company as of October 29, 2025 increased by roughly 0.1 million, not 1 million, since its last update on October 6, 2025. A corrected copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. Information contained on or accessible through any website reference in the press release is not part of, or incorporated by reference in, this report, and the inclusion of such website addresses in this report by incorporation by reference of the press release is as inactive textual references only. Exhibit 99.1 hereto contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are based on current expectations and are not guarantees of future performance. Further, the forward-looking statements are subject to the limitations listed in Exhibit 99.1 and in the other reports of the Company filed with the Securities and Exchange Commission, including that actual events or results may differ materially from those in the forward-looking statements. The information in this report, including Exhibit 99.1 hereto, is furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. The Company's submission of this report shall not be deemed an admission as to the materiality of any information required to be

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated October 29, 2025 (corrected) . 104 Cover Page Interactive Data File (embedded within Inline XBRL document). 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SOLANA COMPANY. Dated: October 29, 2025 By: /s/ Joseph Chee Joseph Chee Executive Chairman 3

View Full Filing

View this 8-K filing on SEC EDGAR